SDAM
ENZ

Shulman DeMeo Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Shulman DeMeo Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,487
Closed -$5.73K – 120
2025
Q1 		$5.73K Hold
15,487
– – ﹤0.01% 116
2024
Q4 		$11.1K Hold
15,487
– – ﹤0.01% 118
2024
Q3 		$17.3K Hold
15,487
– – ﹤0.01% 132
2024
Q2 		$16.9K Hold
15,487
– – ﹤0.01% 128
2024
Q1 		$19.7K Hold
15,487
– – 0.01% 133
2023
Q4 		$21.5K Hold
15,487
– – 0.01% 135
2023
Q3 		$21.7K Hold
15,487
– – 0.01% 128
2023
Q2 		$28.5K Hold
15,487
– – 0.01% 131
2023
Q1 		$37.6K Hold
15,487
– – 0.01% 135
2022
Q4 		$22.1K Hold
15,487
– – 0.01% 134
2022
Q3 		$35K Buy
+15,487
New +$37.4K 0.01% 129

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Shulman DeMeo Asset Management's ENZ Position: Q2 2025 in Review

Shulman DeMeo Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 15,487 shares — an estimated $5.73K sold.

Shulman DeMeo Asset Management first reported a position in ENZ in Q3 2022 and held it in 11 quarters. The position peaked at $37.6K in Q1 2023. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Shulman DeMeo Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Shulman DeMeo Asset Management sold 15,487 Enzo Biochem, Inc. shares in Q2 2025, an estimated $5.73K.
  • Shulman DeMeo Asset Management first reported a position in Enzo Biochem, Inc. in Q3 2022 and held it in 11 quarters.
  • Shulman DeMeo Asset Management's Enzo Biochem, Inc. position peaked at $37.6K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Shulman DeMeo Asset Management's 13F filing for Q2 2025, filed 15 Jul 2025.